Drug Research

SGX-Catalist listed Hyphens Pharma International Limited, Singapore’s leading specialty pharmaceutical and consumer healthcare group, has just announced that its subsidiary, Hyphens Pharma Pte. Ltd., has signed an exclusive sub-license and supply agreement with Hana Pharm Co., Ltd. to develop...

AustinPx, a contract development and manufacturing organization (CDMO) specializing in analytical and formulation development services and cGMP manufacturing for small molecule drugs, expanded its capabilities. The company has added new spray drying and encapsulation capabilities and expanded its GMP...

The worldwide tablet coatings sector generated $2.2 billion in 2021 and is projected to reach $4.1 billion by 2031, growing at a CAGR of 6.6% from 2022 to 2031. Key takeaways include: Increasing pharmaceutical demand: Growing global demand for pharmaceuticals...

Bayer and Bicycle Therapeutics Limited, a biotechnology company pioneering a new and differentiated class of therapeutics by utilizing proprietary bicyclic peptides technology (Bicycle), have entered a strategic collaboration to discover, develop, manufacture, and commercialize Bicycle radio conjugates for multiple...

NewBiologix SA launched as a technology innovation company developing a proprietary and breakthrough platform for the advanced engineering of cell lines used to manufacture gene and cell therapies. The launch also includes the completion of a custom built 19,000...

Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), entered into a collaborative partnership with ScaleReady, a joint venture between Bio-Techne, Fresenius Kabi and Wilson Wolf that brings together...

Ascend Gene & Cell Therapies, a specialist company innovating manufacturing processes to improve quality, potency, safety and cost enabling better reach for gene therapy technologies, announces  that it has launched as a facilitator for gene therapy companies to help...